ALX Oncology Holdings Inc. (ALXO)
NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
At close: 04:00PM EDT
After hours:
| Previous Close | 16.95 |
| Open | 17.50 |
| Bid | 16.15 x 200 |
| Ask | 16.24 x 400 |
| Day's Range | 15.94 - 17.50 |
| 52 Week Range | 3.94 - 17.83 |
| Volume | |
| Avg. Volume | 536,629 |
| Market Cap | 818.585M |
| Beta (5Y Monthly) | 1.30 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | N/A |
| Earnings Date | N/A |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | N/A |
- GuruFocus.com
ALX Oncology Holdings Inc (ALXO) Q1 2024 Earnings Analysis: A Detailed Look at Financials and ...
Consistent with Analyst Projections Amidst Clinical Advancements
- Zacks
Roche's (RHHBY) Combination Therapy Meets Goal in Lymphoma Study
Roche's (RHHBY) Columvi, in combination with GemOx, achieves the primary endpoint of overall survival in a late-stage lymphoma study.
- Zacks
ALX Oncology (ALXO) Posts Upbeat Results From Lymphoma Study
ALX Oncology (ALXO) announces positive results from an early to mid-stage study of an investigational combination regimen to treat indolent and aggressive R/R B-NHL.
© 2024 Yahoo. All rights reserved.